The Good Bug has raised ₹100 crore in funding led by Susquehanna Asia VC, with continued backing from Fireside Ventures. The funds will fuel R&D, product innovation, and nationwide expansion. With 10 lakh+ users, TGB aims to revolutionise gut health using microbiome science. Its latest GLP-1-based solution tackles obesity and gut issues, strengthening its leadership in India's wellness space.